SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Hiroyuki Nawa, Hidekazu Sotoyama, Yuriko Iwakura, Nobuyuki Takei, Hisaaki Namba, Neuropathologic Implication of Peripheral Neuregulin-1 and EGF Signals in Dopaminergic Dysfunction and Behavioral Deficits Relevant to Schizophrenia: Their Target Cells and Time Window, BioMed Research International, 2014, 2014, 1

    CrossRef

  2. 2
    M Mizuno, H Sotoyama, H Namba, M Shibuya, T Eda, R Wang, T Okubo, K Nagata, Y Iwakura, H Nawa, ErbB inhibitors ameliorate behavioral impairments of an animal model for schizophrenia: implication of their dopamine-modulatory actions, Translational Psychiatry, 2013, 3, 4, e252

    CrossRef

  3. 3
    Hidekazu Sotoyama, Hisaaki Namba, Satomi Chiken, Atsushi Nambu, Hiroyuki Nawa, Exposure to the cytokine EGF leads to abnormal hyperactivity of pallidal GABA neurons: implications for schizophrenia and its modeling, Journal of Neurochemistry, 2013, 126, 4
  4. 4
    Takeyoshi Eda, Makoto Mizuno, Kazuaki Araki, Yuriko Iwakura, Hisaaki Namba, Hidekazu Sotoyama, Akiyoshi Kakita, Hitoshi Takahashi, Hiroshi Satoh, Siu-Yuen Chan, Hiroyuki Nawa, Neurobehavioral deficits of epidermal growth factor-overexpressing transgenic mice: Impact on dopamine metabolism, Neuroscience Letters, 2013, 547, 21

    CrossRef

  5. 5
    C. D. Bryant, L. A. Kole, M. A. Guido, G. Sokoloff, A. A. Palmer, Congenic dissection of a major QTL for methamphetamine sensitivity implicates epistasis, Genes, Brain and Behavior, 2012, 11, 5
  6. 6
    Yuriko Iwakura, Yingjun Zheng, Maria Sibilia, Yuichi Abe, Ying-shan Piao, Daisaku Yokomaku, Ran Wang, Yuta Ishizuka, Nobuyuki Takei, Hiroyuki Nawa, Qualitative and quantitative re-evaluation of epidermal growth factor-ErbB1 action on developing midbrain dopaminergic neurons in vivo and in vitro: target-derived neurotrophic signaling (Part 1), Journal of Neurochemistry, 2011, 118, 1
  7. You have free access to this content7
    Yuichiro Watanabe, Toshiyuki Someya, Hiroyuki Nawa, Cytokine hypothesis of schizophrenia pathogenesis: Evidence from human studies and animal models, Psychiatry and Clinical Neurosciences, 2010, 64, 3
  8. 8
    J. S. Brown, Effects of Bisphenol-A and Other Endocrine Disruptors Compared With Abnormalities of Schizophrenia: An Endocrine-Disruption Theory of Schizophrenia, Schizophrenia Bulletin, 2009, 35, 1, 256

    CrossRef

  9. 9
    H. Namba, Y. Zheng, Y. Abe, H. Nawa, Epidermal growth factor administered in the periphery influences excitatory synaptic inputs onto midbrain dopaminergic neurons in postnatal mice, Neuroscience, 2009, 158, 4, 1731

    CrossRef

  10. 10
    Y. Abe, H. Namba, Y. Zheng, H. Nawa, In situ hybridization reveals developmental regulation of ErbB1-4 mRNA expression in mouse midbrain: Implication of ErbB receptors for dopaminergic neurons, Neuroscience, 2009, 161, 1, 95

    CrossRef

  11. 11
    Noriko Tsuda, Makoto Mizuno, Takayuki Yamanaka, Toshi Komurasaki, Makoto Yoshimoto, Hiroyuki Nawa, Common behavioral influences of the ErbB1 ligands transforming growth factor alpha and epiregulin administered to mouse neonates, Brain and Development, 2008, 30, 8, 533

    CrossRef

  12. 12
    Yumiko Ikeda, Noriaki Yahata, Itsuo Ito, Masatoshi Nagano, Tomoko Toyota, Takeo Yoshikawa, Yoshiro Okubo, Hidenori Suzuki, Low serum levels of brain-derived neurotrophic factor and epidermal growth factor in patients with chronic schizophrenia, Schizophrenia Research, 2008, 101, 1-3, 58

    CrossRef

  13. 13
    M. Mizuno, H. Kawamura, N. Takei, H. Nawa, The anthraquinone derivative Emodin ameliorates neurobehavioral deficits of a rodent model for schizophrenia, Journal of Neural Transmission, 2008, 115, 3, 521

    CrossRef

  14. 14
    Hidekazu Sotoyama, Hisaaki Namba, Nobuyuki Takei, Hiroyuki Nawa, Neonatal exposure to epidermal growth factor induces dopamine D2-like receptor supersensitivity in adult sensorimotor gating, Psychopharmacology, 2007, 191, 3, 783

    CrossRef

  15. 15
    Thomas M. Tzschentke, REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade, Addiction Biology, 2007, 12, 3-4
  16. 16
    Sampsa Puttonen, Liisa Keltikangas-Järvinen, Marko Elovainio, Mika Kivimäki, Riikka Rontu, Terho Lehtimäki, Temperamental Activity and Epidermal Growth Factor A61G Polymorphism in Finnish Adults, Neuropsychobiology, 2007, 56, 4, 208

    CrossRef

  17. 17
    Yingjun Zheng, Kousuke Sudou, Hiroyuki Nawa, Hisaaki Namba, Field potential recording in the ventral tegmental area: Pharmacological and toxicological evaluations of postsynaptic dopaminergic neuron activity, Neuroscience Research, 2006, 55, 4, 426

    CrossRef

  18. 18
    Juan José Chiesa, John Fontenele Araujo, Antoni Díez-Noguera, Method for studying behavioural activity patterns during long-term recordings using a force-plate actometer, Journal of Neuroscience Methods, 2006, 158, 1, 157

    CrossRef

  19. 19
    Hiroyuki Nawa, Nori Takei, Recent progress in animal modeling of immune inflammatory processes in schizophrenia: Implication of specific cytokines, Neuroscience Research, 2006, 56, 1, 2

    CrossRef

  20. 20
    Manavu Tohmi, Noriko Tsuda, Makoto Mizuno, Nobuyuki Takei, Paul W. Frankland, Hiroyuki Nawa, Distinct Influences of Neonatal Epidermal Growth Factor Challenge on Adult Neurobehavioral Traits in Four Mouse Strains, Behavior Genetics, 2005, 35, 5, 615

    CrossRef

  21. 21
    Yuichiro Watanabe, Naoki Fukui, Tatsuyuki Muratake, Naoshi Kaneko, Toshiyuki Someya, No association of EGF polymorphism with schizophrenia in a Japanese population, NeuroReport, 2005, 16, 4, 403

    CrossRef